nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—adrenal gland cancer	0.863	1	CbGaD
Etoricoxib—Vemurafenib—BRAF—adrenal gland cancer	0.0117	0.819	CrCbGaD
Etoricoxib—CYP2C19—urine—adrenal gland cancer	0.00319	0.165	CbGeAlD
Etoricoxib—CYP1A2—urine—adrenal gland cancer	0.0026	0.135	CbGeAlD
Etoricoxib—CYP2C9—urine—adrenal gland cancer	0.00247	0.128	CbGeAlD
Etoricoxib—CYP2E1—urine—adrenal gland cancer	0.00234	0.121	CbGeAlD
Etoricoxib—CYP3A4—urine—adrenal gland cancer	0.00188	0.0978	CbGeAlD
Etoricoxib—CYP2D6—urine—adrenal gland cancer	0.00185	0.0962	CbGeAlD
Etoricoxib—MAPK14—pituitary gland—adrenal gland cancer	0.0016	0.0833	CbGeAlD
Etoricoxib—Celecoxib—PTGS2—adrenal gland cancer	0.0015	0.105	CrCbGaD
Etoricoxib—MAPK14—adrenal gland—adrenal gland cancer	0.00143	0.0744	CbGeAlD
Etoricoxib—Vismodegib—ABCB1—adrenal gland cancer	0.00109	0.0763	CrCbGaD
Etoricoxib—PTGS2—adrenal cortex—adrenal gland cancer	0.000571	0.0296	CbGeAlD
Etoricoxib—MAPK14—Leptin signaling pathway—BAD—adrenal gland cancer	0.000497	0.00479	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of retinoblastoma protein—RB1—adrenal gland cancer	0.000492	0.00475	CbGpPWpGaD
Etoricoxib—MAPK14—TSH signaling pathway—RB1—adrenal gland cancer	0.000492	0.00475	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—adrenal gland cancer	0.000489	0.00472	CbGpPWpGaD
Etoricoxib—MAPK14—CDC42 signaling events—BRAF—adrenal gland cancer	0.000478	0.00461	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—CDKN2A—adrenal gland cancer	0.000473	0.00457	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000467	0.0045	CbGpPWpGaD
Etoricoxib—PTGS2—pituitary gland—adrenal gland cancer	0.000461	0.0239	CbGeAlD
Etoricoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000454	0.00438	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—CDC42—adrenal gland cancer	0.000453	0.00437	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000451	0.00435	CbGpPWpGaD
Etoricoxib—CYP2E1—adrenal gland—adrenal gland cancer	0.000448	0.0232	CbGeAlD
Etoricoxib—MAPK14—MAPK Signaling Pathway—PRKACA—adrenal gland cancer	0.00044	0.00425	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of retinoblastoma protein—CDKN2A—adrenal gland cancer	0.000433	0.00417	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.000426	0.00411	CbGpPWpGaD
Etoricoxib—MAPK14—p73 transcription factor network—RB1—adrenal gland cancer	0.000426	0.00411	CbGpPWpGaD
Etoricoxib—MAPK14—RAC1 signaling pathway—CTNNB1—adrenal gland cancer	0.000425	0.0041	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NR5A1—adrenal gland cancer	0.000424	0.00409	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—CDC42—adrenal gland cancer	0.000422	0.00407	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00042	0.00405	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.000419	0.00404	CbGpPWpGaD
Etoricoxib—PTGS2—adrenal gland—adrenal gland cancer	0.000412	0.0214	CbGeAlD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.0004	0.00386	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—POMC—adrenal gland cancer	0.000389	0.00375	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—CDC42—adrenal gland cancer	0.000384	0.00371	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—BRAF—adrenal gland cancer	0.000384	0.0037	CbGpPWpGaD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—adrenal gland cancer	0.000374	0.00361	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.000374	0.00361	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—CDC42—adrenal gland cancer	0.000373	0.0036	CbGpPWpGaD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—BRAF—adrenal gland cancer	0.000368	0.00355	CbGpPWpGaD
Etoricoxib—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000368	0.00355	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TERT—adrenal gland cancer	0.000363	0.0035	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—IGF1R—adrenal gland cancer	0.000362	0.00349	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—adrenal gland cancer	0.000358	0.00345	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—adrenal gland cancer	0.000353	0.00341	CbGpPWpGaD
Etoricoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000351	0.00338	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—BRAF—adrenal gland cancer	0.000345	0.00333	CbGpPWpGaD
Etoricoxib—MAPK14—CDC42 signaling events—CTNNB1—adrenal gland cancer	0.000345	0.00333	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—RB1—adrenal gland cancer	0.000339	0.00328	CbGpPWpGaD
Etoricoxib—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000329	0.00318	CbGpPWpGaD
Etoricoxib—MAPK14—Thromboxane A2 receptor signaling—EGFR—adrenal gland cancer	0.000327	0.00316	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CDC42—adrenal gland cancer	0.000316	0.00305	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000316	0.00305	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.0003	0.00289	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—adrenal gland cancer	0.000298	0.00288	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—CDKN2A—adrenal gland cancer	0.000298	0.00288	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—BAD—adrenal gland cancer	0.000295	0.00284	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000289	0.00279	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000288	0.00278	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—PRKACA—adrenal gland cancer	0.000288	0.00277	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.000287	0.00277	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—EGFR—adrenal gland cancer	0.000283	0.00273	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.000278	0.00268	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—CDKN2A—adrenal gland cancer	0.00027	0.0026	CbGpPWpGaD
Etoricoxib—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000267	0.00257	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—TP53—adrenal gland cancer	0.000263	0.00254	CbGpPWpGaD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000255	0.00247	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MED12—adrenal gland cancer	0.000255	0.00246	CbGpPWpGaD
Etoricoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000254	0.00245	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.000246	0.00237	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000245	0.00236	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	0.000244	0.00236	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.000244	0.00235	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	0.000238	0.0023	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000238	0.00229	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—BRAF—adrenal gland cancer	0.000237	0.00229	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000235	0.00227	CbGpPWpGaD
Etoricoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000234	0.00226	CbGpPWpGaD
Etoricoxib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000234	0.00225	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.000232	0.00224	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—SH3KBP1—adrenal gland cancer	0.000232	0.00224	CbGpPWpGaD
Etoricoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000232	0.00223	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.000228	0.0022	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.000221	0.00214	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NR5A1—adrenal gland cancer	0.000217	0.00209	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—SPARC—adrenal gland cancer	0.000216	0.00208	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—RB1—adrenal gland cancer	0.000215	0.00207	CbGpPWpGaD
Etoricoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000214	0.00206	CbGpPWpGaD
Etoricoxib—MAPK14—Cell-Cell communication—CTNNB1—adrenal gland cancer	0.00021	0.00203	CbGpPWpGaD
Etoricoxib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000206	0.00199	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.000202	0.00195	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000202	0.00195	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000201	0.00194	CbGpPWpGaD
Etoricoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000198	0.00191	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—RB1—adrenal gland cancer	0.000198	0.00191	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000195	0.00188	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000194	0.00187	CbGpPWpGaD
Etoricoxib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000189	0.00183	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CDKN2A—adrenal gland cancer	0.000189	0.00182	CbGpPWpGaD
Etoricoxib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000188	0.00181	CbGpPWpGaD
Etoricoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000183	0.00176	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PRKACA—adrenal gland cancer	0.000182	0.00176	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000173	0.00167	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—BAD—adrenal gland cancer	0.00017	0.00164	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	0.000166	0.0016	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PRKACA—adrenal gland cancer	0.000164	0.00158	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—RB1—adrenal gland cancer	0.000162	0.00157	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GNRHR—adrenal gland cancer	0.000161	0.00156	CbGpPWpGaD
Etoricoxib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00016	0.00155	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CDC42—adrenal gland cancer	0.000158	0.00152	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—BRAF—adrenal gland cancer	0.000155	0.0015	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000155	0.00149	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—CDC42—adrenal gland cancer	0.000155	0.00149	CbGpPWpGaD
Etoricoxib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000153	0.00147	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—adrenal gland cancer	0.00015	0.00145	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00015	0.00145	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00015	0.00145	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IGF2—adrenal gland cancer	0.000149	0.00144	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—GNAS—adrenal gland cancer	0.000148	0.00142	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000145	0.0014	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.000143	0.00138	CbGpPWpGaD
Etoricoxib—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.000142	0.00137	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000141	0.00136	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.00014	0.00135	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CDC42—adrenal gland cancer	0.000139	0.00134	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000138	0.00134	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000138	0.00134	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—adrenal gland cancer	0.000138	0.00133	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SH3KBP1—adrenal gland cancer	0.000137	0.00132	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000136	0.00131	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SDHB—adrenal gland cancer	0.000135	0.0013	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MED12—adrenal gland cancer	0.00013	0.00126	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ZNRF3—adrenal gland cancer	0.000129	0.00124	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.000127	0.00122	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MEN1—adrenal gland cancer	0.000124	0.0012	CbGpPWpGaD
Etoricoxib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000124	0.00119	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000123	0.00118	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000115	0.00111	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000115	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000114	0.0011	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000109	0.00106	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000106	0.00102	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000105	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—adrenal gland cancer	0.000105	0.00101	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000103	0.000993	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000101	0.000971	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	9.97e-05	0.000962	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	9.88e-05	0.000954	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SDHB—adrenal gland cancer	9.78e-05	0.000943	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—BAD—adrenal gland cancer	9.71e-05	0.000937	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—adrenal gland cancer	9.66e-05	0.000932	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GNRH1—adrenal gland cancer	9.66e-05	0.000932	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	9.62e-05	0.000928	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PRKACA—adrenal gland cancer	9.55e-05	0.000922	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SDHB—adrenal gland cancer	8.99e-05	0.000868	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SDHB—adrenal gland cancer	8.92e-05	0.00086	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—EGFR—adrenal gland cancer	8.87e-05	0.000856	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SPRY2—adrenal gland cancer	8.83e-05	0.000852	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RRM1—adrenal gland cancer	8.68e-05	0.000837	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SDHD—adrenal gland cancer	8.68e-05	0.000837	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TSHR—adrenal gland cancer	8.61e-05	0.00083	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	8.52e-05	0.000822	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.22e-05	0.000793	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RRM1—adrenal gland cancer	8.17e-05	0.000788	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SDHD—adrenal gland cancer	8.17e-05	0.000788	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDC42—adrenal gland cancer	8.1e-05	0.000782	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MEN1—adrenal gland cancer	8.09e-05	0.000781	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SPRY2—adrenal gland cancer	8.06e-05	0.000777	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—adrenal gland cancer	7.94e-05	0.000766	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	7.83e-05	0.000755	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.7e-05	0.000743	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SDHB—adrenal gland cancer	7.62e-05	0.000735	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MEN1—adrenal gland cancer	7.38e-05	0.000712	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CTNNB1—adrenal gland cancer	7.23e-05	0.000698	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.02e-05	0.000677	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	6.58e-05	0.000635	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	6.57e-05	0.000634	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MED12—adrenal gland cancer	6.47e-05	0.000624	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CTNNB1—adrenal gland cancer	6.39e-05	0.000616	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RRM1—adrenal gland cancer	6.3e-05	0.000608	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SDHD—adrenal gland cancer	6.3e-05	0.000608	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRKACA—adrenal gland cancer	6.18e-05	0.000596	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MED12—adrenal gland cancer	6.09e-05	0.000588	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6e-05	0.000579	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	5.88e-05	0.000567	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RRM1—adrenal gland cancer	5.8e-05	0.000559	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SDHD—adrenal gland cancer	5.8e-05	0.000559	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.78e-05	0.000558	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SDHD—adrenal gland cancer	5.75e-05	0.000554	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RRM1—adrenal gland cancer	5.75e-05	0.000554	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—adrenal gland cancer	5.73e-05	0.000553	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—BAD—adrenal gland cancer	5.65e-05	0.000546	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRKACA—adrenal gland cancer	5.63e-05	0.000544	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDC42—adrenal gland cancer	5.24e-05	0.000505	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—adrenal gland cancer	5.06e-05	0.000488	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF2—adrenal gland cancer	5.05e-05	0.000487	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GNAS—adrenal gland cancer	5.01e-05	0.000483	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RRM1—adrenal gland cancer	4.91e-05	0.000474	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SDHD—adrenal gland cancer	4.91e-05	0.000474	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1R—adrenal gland cancer	4.88e-05	0.000471	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDC42—adrenal gland cancer	4.78e-05	0.000461	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—adrenal gland cancer	4.72e-05	0.000455	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PRKACA—adrenal gland cancer	4.72e-05	0.000455	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MED12—adrenal gland cancer	4.7e-05	0.000453	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	4.44e-05	0.000429	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MED12—adrenal gland cancer	4.32e-05	0.000417	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MED12—adrenal gland cancer	4.28e-05	0.000413	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TERT—adrenal gland cancer	4.2e-05	0.000406	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.2e-05	0.000405	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TERT—adrenal gland cancer	3.83e-05	0.00037	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.83e-05	0.000369	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GNAS—adrenal gland cancer	3.82e-05	0.000369	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.79e-05	0.000366	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.79e-05	0.000366	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ABCB1—adrenal gland cancer	3.75e-05	0.000362	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTNNB1—adrenal gland cancer	3.72e-05	0.000359	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MED12—adrenal gland cancer	3.66e-05	0.000353	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BAD—adrenal gland cancer	3.66e-05	0.000353	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GNAS—adrenal gland cancer	3.6e-05	0.000347	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	3.53e-05	0.000341	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	3.43e-05	0.000331	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—adrenal gland cancer	3.37e-05	0.000325	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.35e-05	0.000323	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—BAD—adrenal gland cancer	3.34e-05	0.000322	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BRAF—adrenal gland cancer	3.33e-05	0.000321	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.27e-05	0.000316	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	3.15e-05	0.000304	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	3.12e-05	0.000302	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.05e-05	0.000295	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—BRAF—adrenal gland cancer	3.04e-05	0.000293	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—adrenal gland cancer	2.95e-05	0.000284	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.83e-05	0.000273	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.78e-05	0.000268	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.73e-05	0.000263	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	2.67e-05	0.000258	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.61e-05	0.000252	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—adrenal gland cancer	2.58e-05	0.000248	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.55e-05	0.000247	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2.53e-05	0.000244	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.51e-05	0.000242	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	2.49e-05	0.00024	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—adrenal gland cancer	2.42e-05	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—adrenal gland cancer	2.41e-05	0.000232	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—adrenal gland cancer	2.19e-05	0.000212	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GNAS—adrenal gland cancer	2.16e-05	0.000209	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	2.12e-05	0.000205	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	2.06e-05	0.000199	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	1.93e-05	0.000187	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—adrenal gland cancer	1.91e-05	0.000184	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.87e-05	0.00018	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—adrenal gland cancer	1.74e-05	0.000168	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.72e-05	0.000166	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.71e-05	0.000165	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.67e-05	0.000161	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.64e-05	0.000158	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—adrenal gland cancer	1.6e-05	0.000154	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.49e-05	0.000144	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.46e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.37e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.36e-05	0.000131	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	1.16e-05	0.000112	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.12e-05	0.000109	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.97e-06	8.66e-05	CbGpPWpGaD
